6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2022

Filing Information

Form Type	6-K
Accession Number	`0001213900-22-050930`
Period End Date	20220630
Filing Date	20220825
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	ea164781-6k_collplant_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 48 Cash Flow Statement 67 Stockholders Equity 30

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.15M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.29M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	11.09M	shares	Point-in-time
Short term cash deposits	`DepositsAssetsCurrent`	$30.15M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	11.09M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	10.77M	shares	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$13.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$23.00K	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	10.77M	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$9.00K	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$270.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$424.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$594.00K	USD	Point-in-time
Inventories	`InventoryNet`	$1.08M	USD	Point-in-time
Inventories	`InventoryNet`	$1.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$45.09M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.27M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$189.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$213.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.79M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.95M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.92M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.73M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$243.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$235.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.14M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.14M	USD	Point-in-time
Total assets	`Assets`	$51.22M	USD	Point-in-time
Total assets	`Assets`	$44.41M	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$760.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$1.03M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$519.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$477.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	-	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$32.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.12M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.36M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.09M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.55M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.55M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.10M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2022 and December 31, 2021; issued and outstanding: 11,086,481 and 10,772,024 ordinary shares as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$4.66M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2022 and December 31, 2021; issued and outstanding: 11,086,481 and 10,772,024 ordinary shares as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$4.83M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$116.58M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$114.22M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.94M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$39.51M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$45.12M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$43.20M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$50.65M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$49.44M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$51.22M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$44.41M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$691.00K	USD	1 Quarter
Revenues	`Revenues`	$66.00K	USD	1 Quarter
Revenues	`Revenues`	$132.00K	USD	2 Qtrs
Revenues	`Revenues`	$15.19M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$429.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$43.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$74.00K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$1.31M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$23.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$13.88M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$58.00K	USD	2 Qtrs
Gross Profit	`GrossProfit`	$262.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.84M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.53M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.90M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.38M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.42M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.61M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.17M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-7.95M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$6.96M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-4.18M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-3.06M	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$-192.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$25.00K	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$123.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$-100.00K	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$7.09M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-3.04M	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-4.29M	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$0.76	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.74	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.39	USD	1 Quarter
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasic`	$-0.30	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.30	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.74	USD	2 Qtrs
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.39	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareDiluted`	$0.58	USD	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	10.94M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	9.32M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.09M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	10.20M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.20M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.94M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.09M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.17M	shares	2 Qtrs

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Income (loss)	`ProfitLoss`	$-7.09M	USD	2 Qtrs
Income (loss)	`ProfitLoss`	$8.14M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$501.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$352.00K	USD	2 Qtrs
Gains from Short term cash deposits	`ProceedsFromShortTermDebt`	$-87.00K	USD	2 Qtrs
Gains from Short term cash deposits	`ProceedsFromShortTermDebt`	$-74.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$954.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$1.05M	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-727.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-13.00K	USD	2 Qtrs
Financial Income related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	-	USD	2 Qtrs
Financial Income related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-28.00K	USD	2 Qtrs
Decrease in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-553.00K	USD	2 Qtrs
Decrease in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-261.00K	USD	2 Qtrs
Decrease (increase) in inventories	`IncreaseDecreaseInInventories`	$275.00K	USD	2 Qtrs
Decrease (increase) in inventories	`IncreaseDecreaseInInventories`	$-322.00K	USD	2 Qtrs
Increase in other receivables	`IncreaseDecreaseInOtherReceivables`	$740.00K	USD	2 Qtrs
Increase in other receivables	`IncreaseDecreaseInOtherReceivables`	$170.00K	USD	2 Qtrs
Decrease in operating right of use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$220.00K	USD	2 Qtrs
Decrease in operating right of use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$188.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-274.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-100.00K	USD	2 Qtrs
Decrease in lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-272.00K	USD	2 Qtrs
Decrease in lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-643.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-309.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-305.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-32.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-207.00K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`AdjustmentForNetCashProvidedByUsedInOperations`	$7.74M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`AdjustmentForNetCashProvidedByUsedInOperations`	$-7.17M	USD	2 Qtrs
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	$12.00K	USD	2 Qtrs
Capitalization of intangible assets	`PaymentsToAcquireIntangibleAssets`	$82.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$678.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$365.00K	USD	2 Qtrs
Repayment of a short term deposits	`ProceedFromOtherShortTermDebt`	$50.24M	USD	2 Qtrs
Investment in short term deposits	`PaymentsToAcquireShortTermInvestments`	$30.00M	USD	2 Qtrs
Investment in short term deposits	`PaymentsToAcquireShortTermInvestments`	$20.00M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$29.55M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-30.45M	USD	2 Qtrs
Proceeds from issuance of shares and warrants less issuance expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	-	USD	2 Qtrs
Proceeds from issuance of shares and warrants less issuance expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$32.74M	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromStockOptionsExercised`	$4.13M	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromStockOptionsExercised`	$1.47M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.47M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$36.87M	USD	2 Qtrs
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-727.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-13.00K	USD	2 Qtrs
Net increase in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.15M	USD	2 Qtrs
Net increase in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.13M	USD	2 Qtrs
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.37M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.68M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.50M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.37M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.68M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$36.50M	USD	Point-in-time
Obtaining right of use assets in exchange for a lease liability	`CapitalLeaseObligationsIncurred`	$59.00K	USD	2 Qtrs
Obtaining right of use assets in exchange for a lease liability	`CapitalLeaseObligationsIncurred`	$184.00K	USD	2 Qtrs
Classification of issuance costs liability to equity	`ProceedsFromIssuanceCosts`	$50.00K	USD	2 Qtrs
Classification of issuance costs liability to equity	`ProceedsFromIssuanceCosts`	-	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalent`	$17.48M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalent`	$36.29M	USD	2 Qtrs
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$190.00K	USD	2 Qtrs
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$212.00K	USD	2 Qtrs
Total cash and cash equivalents and restricted deposits	`TotalCashAndCashEquivalentsAndRestrictedDeposits`	$36.50M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`TotalCashAndCashEquivalentsAndRestrictedDeposits`	$17.68M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares and warrants, net of issuance costs	`OrdinarySharesAndWarrantsNetOfIssuanceCosts`	$3.20K	USD	2 Qtrs
Exercise of warrants, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$17.00K	USD	1 Quarter
Exercise of warrants, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$51.00K	USD	2 Qtrs
Balance	`StockholdersEquity`	$39.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$43.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$50.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.44M	USD	Point-in-time
Issuance of ordinary shares and warrants, net of issuance costs of $3.2M	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$32.79M	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$174.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$110.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	1 Quarter
Exercise of warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.30M	USD	2 Qtrs
Exercise of warrants, net of issuance costs of $17	`StockIssuedDuringPeriodValueOther`	$4.02M	USD	2 Qtrs
Exercise of warrants, net of issuance costs of $17	`StockIssuedDuringPeriodValueOther`	$1.35M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectsFromShareBasedCompensation`	$469.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectsFromShareBasedCompensation`	$1.05M	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectsFromShareBasedCompensation`	$594.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectsFromShareBasedCompensation`	$954.00K	USD	2 Qtrs
Comprehensive profit (loss)	`OtherComprehensiveIncomeLossTax`	$-3.04M	USD	1 Quarter
Comprehensive profit (loss)	`OtherComprehensiveIncomeLossTax`	$-8.14M	USD	2 Qtrs
Comprehensive profit (loss)	`OtherComprehensiveIncomeLossTax`	$7.09M	USD	2 Qtrs
Comprehensive profit (loss)	`OtherComprehensiveIncomeLossTax`	$-4.29M	USD	1 Quarter
Balance	`StockholdersEquity`	$39.51M	USD	Point-in-time
Balance	`StockholdersEquity`	$45.12M	USD	Point-in-time
Balance	`StockholdersEquity`	$43.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$50.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.